WILMINGTON, DE / ACCESSWIRE / February 6, 2023 / Transparency Market Research Inc. - According to a TMR study, the global lung disease therapeutics market is projected to grow at a CAGR of 3.7% during the forecast period from 2022 to 2031.

Lung disease therapeutics refers to a range of treatments and drugs that are used to manage different lung diseases in patients. Demand for these therapeutics is high among patients suffering from both acute and chronic respiratory disorders.

Launch of new therapeutics is anticipated to help leading players to generate revenue and gain a competitive edge over other players. Additionally, prominent players are collaborating with other players to expand presence and increase revenue shares in thelung disease therapeutic market.

In August 2022, Astrazeneca India signed a collaborative agreement with Alveofit to offer handheld spirometers enabled with IoT technology in hospitals across India.

Request to Sample PDF of this Strategic Report (Use Corporate Mail ID for Top Priority): https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85362

Key Findings of Market Study

• Growing Prevalence of Asthma: Based on disease type, the global market has been divided into asthma, lung cancer, chronic obstructive pulmonary disease (COPD), and other lung diseases. The asthma segment accounted for dominant share in 2021. Increase in patient population suffering from asthma and rise in need for different types of medication, such as beta-agonists, inhaled corticosteroids, and leukotriene modifiers, to manage asthma, are driving the segment.
• Increase in Demand for Corticosteroids: In terms of drug type, the global market has been classified into corticosteroids, mucolytics, antimicrobial medications, bronchodilator medications, and others. The corticosteroids segment accounted for significant market share in 2021. Rise in demand among patients suffering from asthma and COPD to decrease inflammation in airways and help improve breathing is driving the segment. Corticosteroids have shown high effectiveness in helping patients recover from different lung disorders, which is likely to fuel product demand during the forecast period.
• Rise in Patient Preference to Purchase Medication from Hospital Pharmacies: Based on distribution channel, the global market has been split into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment accounted for leading market share in 2021. Increase in patient preference for purchasing lung disease medication from hospital pharmacies is augmenting the segment. Additionally, availability of specialized medication at hospital pharmacies to treat lung disorders is driving the segment.

Lung Disease Therapeutics Market - Key Drivers

• Rise in prevalence of lung cancer is driving the global lung disease therapeutics market
• Increase in adoption of early detection methods and screening is anticipated to expand market size during the forecast period
• Surge in COPD incidences across the world is projected to drive industry growth in the next few years

Buy this Premium Research Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=85362<>

Lung Disease Therapeutics Market - Regional Landscape

North America accounted for dominant market share in 2021. Increase in prevalence of lung diseases, such as asthma and COPD, and presence of developed healthcare infrastructure in countries, such as the U.S. and Canada, are bolstering market development in the region.

Lung Disease Therapeutics Market - Key Players

The global market is competitive, with the presence of several international and local players. Entry of new players is anticipated to intensify the competition during the forecast period.

Leading players are investing in R&D to manufacture improved therapeutic products. Increase in demand for improved therapeutic products among patients is likely to drive industry growth during the forecast period.

Prominent players operating in the lung disease therapeutics market are Astrazeneca, GSK, Fibrogen, Teva Pharmaceuticals, and Liminal Biosciences.

The global market has been segmented as follows:

• Disease Type
• Asthma
• Lung Cancer
• Chronic Obstructive Pulmonary Disease (COPD)
• Other Lung Diseases
• Drug Class
• Corticosteroids
• Mucolytics
• Antimicrobial Medications
• Bronchodilator Medications
• Others
• Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa

Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=85362

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Severe Acute Respiratory Syndrome Treatment Market

Ischemia Reperfusion Injury Therapeutics Market

Small Cell Lung Cancer (SCLC) Therapeutics Market

COVID-19 Therapeutics Market

T-cell Therapy Market

Catheter-related Bloodstream Infections Market

Breathing Circuits Market

Pediatric Asthma Treatment Market

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

SOURCE: Transparency Market Research inc.